Praxis 精準醫學有限公司
US ˙ NasdaqGS ˙ US74006W2070

SecurityPRAX / Praxis Precision Medicines, Inc.
InstitutionQUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series
Latest Disclosed Ownership29,076 shares
Latest Disclosed Value $ 1,222,645
QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series ownership in PRAX / Praxis Precision Medicines, Inc.

On August 26, 2025 - QUANTITATIVE MASTER SERIES LLC - Master Small Cap Index Series filed a NPORT-P form disclosing ownership of 29,076 shares of Praxis Precision Medicines, Inc. (US:PRAX) valued at $1,222,646 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 28, 2025 disclosing 29,076 shares of Praxis Precision Medicines, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $7,385,304 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-26 2025-06-30 NP Praxis Precision Medicines EC US74006W2070 29,076 0 0.00 1,223 10.99 0.0275
2025-05-28 2025-03-31 NP Praxis Precision Medicines EC US74006W2070 29,076 0 0.00 1,101 -50.78 0.0264
2025-02-25 2024-12-31 NP Praxis Precision Medicines EC US74006W2070 29,076 -5,079 -14.87 2,238 13.84 0.0489
2024-11-26 2024-09-30 NP Praxis Precision Medicines EC US74006W2070 34,155 34,155 1,965 0.0372
2023-08-25 2023-06-30 NP Praxis Precision Medicines EC US74006W1080 0 -63,406 -100.00 0 -100.00
2023-05-26 2023-03-31 NP Praxis Precision Medicines EC US74006W1080 63,406 10,627 20.13 51 -59.20 0.0014
2023-02-24 2022-12-31 NP Praxis Precision Medicines EC US74006W1080 52,779 0 0.00 126 5.04 0.0035
2022-11-25 2022-09-30 NP Praxis Precision Medicines EC US74006W1080 52,779 0 0.00 120 -7.75 0.0034
2022-08-25 2022-06-30 NP Praxis Precision Medicines EC US74006W1080 52,779 0 0.00 129 -76.02 0.0036
2022-05-26 2022-03-31 NP Praxis Precision Medicines EC US74006W1080 52,779 3,042 6.12 539 -45.05 0.0126
2022-02-25 2021-12-31 NP Praxis Precision Medicines EC US74006W1080 49,737 0 0.00 980 6.53 0.0213
2021-11-24 2021-09-30 NP Praxis Precision Medicines EC US74006W1080 49,737 13,105 35.77 920 37.37 0.0203
2021-08-26 2021-06-30 NP Praxis Precision Medicines EC US74006W1080 36,632 19,730 116.73 670 20.98 0.0144
2021-05-27 2021-03-31 NP Praxis Precision Medicines EC US74006W1080 16,902 0 0.00 554 -40.47 0.0126
2021-02-25 2020-12-31 NP Praxis Precision Medicines EC US74006W1080 16,902 16,902 930 0.0238
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.